Functional analyses of lipocalin-type and hematopoietic prostaglandin D synthases

Folia Pharmacologica Japonica

Volumn 123, Issue 1, 2004, Pages 5-13

  Urade, Yoshihiro ^a   Eguchi, Naomi ^a   Aritake, Kosuke ^a   Hayaishi, Osamu ^a  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

Allergy; Clinical marker protein; Gene manipulated mice; Sleep; X ray crystallography

Indexed keywords

BIOCHEMICAL MARKER; LIPOCALIN; PROSTAGLANDIN D SYNTHASE;

ALLERGY; ANIMAL MODEL; ARTICLE; BRAIN; CATALYSIS; CENTRAL NERVOUS SYSTEM; CORONARY ARTERY ATHEROSCLEROSIS; ENZYME ANALYSIS; ENZYME LOCALIZATION; KIDNEY FAILURE; KNOCKOUT GENE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; SLEEP; SLEEP DEPRIVATION; TRANSGENIC MOUSE; X RAY CRYSTALLOGRAPHY;

ANIMALS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MICE;

EID: 0742323626     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.123.5     Document Type: Article

References (51)

1. Urade Y, Hayaishi O. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim Biophys Acta. 2000;1482:259-271.
2. Kanaoka Y, Urade Y. Hematopoietic prostaglandin D synthase. Prostaglandins Leukotrienes Essent. Fatty Acids. 2003;69:163-167.
3. Urade Y, Hayaishi O. Prostaglandin D synthase. Vitam Horm. 2000;58:89-120.
4. Urade Y, Eguchi N. Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat. 2002;68-69:375-382.
5. Urade Y, Fujimoto N, Hayaishi O. Purification and characterization of rat brain prostaglandin D synthetase. J Biol Chem. 1985;260:12410-12415.
6. Irikura D, Kumasaka T, Yamamoto M, et al. Cloning, expression, crystallization, and preliminary X-Ray analysis of recombinant mouse lipocalin-type prostaglandin D synthase, a somnogen-producing enzyme. J Biochem (Tokyo). 2003;133:29-32.
7. Clausen J. Proteins in normal cerebrospinal fluid not found in serum. Proc Soc Exp Biol Med. 1961; 107:170-172.
8. Beuckmann CT, Lazarus M, Gerashchenko D, et al. Cellular localization of lipocalin-type prostaglandin D synthase (beta-trace) in the central nervous system of the adult rat. J Comp Neurol. 2000;428:62-78.
9. Gerena RL, Eguchi N, Irikura D, Urade Y, Killian GJ. Immunocytochemical localization of lipocalin-type prostaglandin D synthase in the bull testis and epididymis and on ejaculated sperm. Biol Reprod. 2000;62:547-556.
10. Gerena RL, Eguchi N, Urade Y, Killian GJ. Stage and region-specific localization of lipocalin-type prostaglandin D synthase in the adult murine testis and epididymis. J Androl. 2000;21:848-854.
11. Eguchi Y, Eguchi N, Oda H, et al. Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci USA. 1997;94:14689-14694.
12. Taba Y, Sasaguri T, Miyagi M, et al. Fluid shear stress induces lipocalin-type prostaglandin D(2) synthase expression in vascular endothelial cells. Circ Res. 2000;86:967-973.
13. Ragolia L, Palaia T, Paric E, Maesaka JK. Prostaglandin D2 synthase inhibits the exaggerated growth phenotype of spontaneously hypertensive rat vascular smooth muscle cells. J Biol Chem. 2003;278:22175-22181.
14. Oda H, Shiina Y, Seiki K, et al. Development and evaluation of a practical ELISA for human urinary lipocalin-type prostaglandin D synthase. Clin Chem. 2002;48:1445-1453.
15. Mase M, Yamada K, Iwata A, et al. Acute and transient increase of lipocalin-type prostaglandin D synthase (beta-trace) level in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage. Neurosci Lett. 1999;270:188-190.
16. Mase M, Shimazu N, Seiki O, et al. Lipocalin-type prostaglandin D synthase (beta-trace) in cerebrospinal fluid: a useful marker for the diagnosis of normal pressure hydrocephalus. Neurosci Res. In press 2003.
17. Hirawa N, Uehara Y, Ikeda T, et al. Urinary prostaglandin D synthase (beta-trace) excretion increases in the early stage of diabetes mellitus. Nephron. 2001;87:321-327.
18. Hamano K, Totsuka Y, Ajima M, et al. Blood sugar control reverses the increase in urinary excretion of prostaglandin D synthase in diabetic patients. Nephron. 2002;92:77-85.
19. Hirawa N, Uehara Y, Yamakado M, et al. Lipocalin-type prostaglandin d synthase in essential hypertension. Hypertension. 2002;39:449-454.
20. Beuckmann CT, Aoyagi M, Okazaki I, et al. Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase. Biochemistry. 1999;38:8006-8013.
21. Garcia-Fernández LF, Iñiguez MA, Eguchi N, et al. Dexamethasone induces lipocalin-type prostaglandin D synthase gene expression in mouse neuronal cells. J Neurochem. 2000;75:460-470.
22. Mong JA, Devidze N, Frail DE, et al. Estradiol differentially regulates lipocalin-type prostaglandin D synthase transcript levels in the rodent brain: evidence from high-density oligonucleotide arrays and in situ hybridization. Proc Natl Acad Sci USA. 2003;100:318-323.
23. Otsuki M, Gao H, Dahlman-Wright K, et al. Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor {beta}. Mol Endocrinol. 2003;17:1844-1855.
24. Fujimori K, Fujitani Y, Kadoyama K, et al. Regulation of lipocalin-type prostaglandin D synthase gene expression by Hes-1 through E-box and interleukin-1 beta via two NF-kappa B elements in rat leptemeningeal cells. J Biol Chem. 2003;278: 6018-6026.
25. Eguchi N, Minami T, Shirafuji N, et al. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci USA. 1999;96:726-730.
26. Pinzar E, Kanaoka Y, Inui T, Eguchi N, Urade Y, Hayaishi O. Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep. Proc Natl Acad Sci USA. 2000;97:4903-4907.
27. Eguchi N, Kuwahata Y, Pinzar E, Mochizuki T, Urade Y, Hayaishi O. Sleep of gene-knockout and transgenic mice for prostaglandin D synthase. Sleep Res. 1999;Online 2 Suppl-1:665.
28. Taniike M, Mohri I, Eguchi N, Beuckmann CT, Suzuki K, Urade YJ. Perineuronal oligodendrocytes protect against neuronal apoptosis through the production of lipocalin-type prostaglandin D synthase in a genetic demyelinating model. J Neurosci. 2002;22:4885-4896.
29. Chabas D, Baranzini SE, Mitchell D, Bernard CC, et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 2001;294:1731-1735.
30. Myerowitz R, Lawson D, Mizukami H, Mi Y, Tifft CJ, Proia RL. Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum Mol Genet. 2002;11:1343-1350.
31. Fujitani Y, Kanaoka Y, Aritake K, Uodome N, Okazaki-Hatake K, Urade Y. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J Immunol. 2002;168:443-449.
32. Christ-Hazelhof E, Nugteren DH. Purification and characterisation of prostaglandin endoperoxide D-isomerase, a cytoplasmic, glutathione-requiring enzyme. Biochim Biophys Acta. 1979;572:43-51.
33. Urade Y, Fujimoto N, Ujihara M, Hayaishi O. Biochemical and immunological characterization of rat spleen prostaglandin D synthetase. J Biol Chem. 1987;262:3820-3825
34. Kanaoka Y, Ago H, Inagaki E, et al. Cloning and crystal structure of hematopoietic prostaglandin D synthase. Cell. 1997;690:1085-1095: ibid Cell 1999; 96: U25.
35. Kanaoka Y, Ago H, Inagaki E, et al. Cloning and crystal structure of hematopoietic prostaglandin D synthase. Cell. 1997;690:1085-1095: ibid Cell 1999; 96: U25.
36. Kanaoka Y, Fujimori K, Kikuno R, Sakaguchi Y, Urade Y, Hayaishi O. Structure and chromosomal localization of human and mouse genes for hematopoietic prostaglandin D synthase. Conservation of the ancestral genomic structure of sigma-class glutathione S-transferase. Eur J Biochem. 2000; 267:3315-3322.
37. Pinzar E, Miyano M, Kanaoka Y, Urade Y, Hayaishi O. Structural basis of hematopoietic prostaglandin D synthase activity elucidated by site-directed mutagenesis. J Biol Chem. 2000;275: 31239-31244.
38. Inoue T, Irikura D, Okazaki N, et al. Mechanism of metal activation of human hematopoietic prostaglandin D synthase. Nat Struct Biol. 2003;10: 291-296.
39. Urade Y, Ujihara M, Horiguchi Y, et al. Mast cells contain spleen-type prostaglandin D synthetase. J Biol Chem. 1990;265:371-375
40. Urade Y, Ujihara M, Horiguchi Y, Ikai K, Hayaishi O. The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. J Immunol. 1989;143: 2982-2989.
41. Mahmud I, Ueda N, Yamaguchi H, et al. Prostaglandin D synthase in human megakaryoblastic cells. J Biol Chem. 1997;272:28263-28266.
42. Tanaka K, Ogawa K, Sugamura K, Nakamura M, Takano S, Nagata KJ. Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. J Immunol. 2000;164:2277-2280.
43. Mohri I, Eguchi N, Suzuki K, Urade Y, Taniike M. Hematopoietic prostaglandin D synthase is expressed in microglia in the developing postnatal mouse brain. Glia. 2003;42:263-274.
44. Noguchi E, Shibasaki M, Ksmioka M, et al. New polymorphisms of haematopoietic prostaglandin D synthase and human prostanoid DP receptor genes. Clin Exp Allergy. 2002;32:93-96.
45. Fujimori K, Kanaoka Y, Sakaguchi Y, Urade Y. Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells. Roles of the oct-1 element in the 5′-flanking region and the AP-2 element in the untranslated exon 1. J Biol Chem. 2000;275: 40511-40516.
46. Li L, Yang L, Stevens RL. RasGRP4 regulates the expression of prostaglandin D2 in human and rat mast cell lines. J Biol Chem. 2003;278:4725-4729.
47. Matsuoka T, Hirata M, Tanaka H, et al. Prostaglandin D2 as a mediator of allergic asthma. Science. 2000;287:2013-2017.
48. Hirai H, Tanaka K, Yoshie O, et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med. 2001; 193:255-261.
49. Matsushita N, Hizue M, Aritake K, et al. Pharmacological studies on the novel antiallergic drug HQL-79: I. Antiallergic and antiasthmatic-effects in various experimental models. Jpn J Pharmacol. 1998;78:1-10.
50. Matsushita N, Aritake K, Takada A, et al. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects. Jpn J Pharmacol. 1998;78:11-22.
51. Okinaga T, Mohri I, Fujimura H, et al. Induction of hematopoietic prostaglandin D synthase in hyalinated necrotic muscle, fibers' its implication in grouped necrosis. Acta Neuropathol (Berl) 2002; 104:377-384.